Cell and gene therapies (C&GTs) are revolutionising medicine, offering the tantalising prospect of cures for diseases once considered incurable. This remarkable ...

The rise of cell and gene therapy (CGT) is revolutionising how we treat complex diseases, offering life-changing treatments for patients in need. However, with these...

Frustration, exhaustion, and a sense of being overwhelmed – these are the hallmarks of “portal fatigue”, a growing problem for approved treatment center (ATC) staff ...

In the world of modern manufacturing and production, staying at the forefront of technology is not just an advantage; it's a necessity. Mabtech understands this well...

Children with medical complexity (CMC) live with congenital or acquired multi-system diseases, severe neurologic conditions with marked functional impairment, and/or...

How truly open access publishing models improve project outcomes for postgraduate research students One of the hardest things about starting a research project is...

It is well-known that going from drug discovery to commercialisation takes, on average, 10–15 years and poses significant costs – approximately $2.6 billion when R&a...

Cell culture is fundamental to many research and industrial processes, but traditional transport methods are fraught with challenges. Cryopreservation, the most comm...

Artificial intelligence (AI) is revolutionising drug discovery, enabling scientists to identify novel therapeutic candidates in a fraction of the time it once requir...

Small molecule microarray (SMM) is a well-established method for identifying small molecule (SM) binding interactions with a diverse range of target types. It has pr...